NEW YORK (GenomeWeb) – Molecular diagnostics firm Invitae said on Monday after the close of the market that it is acquiring Good Start Genetics and CombiMatrix.

Separately, the company announced it would sell $73.5 million of its stock in a private placement and announced preliminary financial results for the second quarter.